SEC Form 4 · accession 0001209191-19-005356
CHIMERIX INC · CMRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
M Michelle Berrey
Officer — President and CEO · Director
Period of report
Jan 23, 2019
Accepted (ET)
Jan 25, 2019 · 4:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001117480
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.41 | Jan 23, 2019 | A | 400,000 | A | — | Jan 22, 2029 | Common Stock | 400,000 | 400,000 | D |
Explanation of responses
- F11/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant.